Evidence map›Paper›PMID 30941230›Full record

ArticleJournal of breast cancer2019

Pokemon Inhibits Transforming Growth Factor β-Smad4-Related Cell Proliferation Arrest in Breast Cancer through Specificity Protein 1.

Ling Chen, Jing Zhong, Jiang-Hua Liu, Duan-Fang Liao, Ying-Ying Shen, Xiao-Lin Zhong, Xiao Xiao, Wen-Jun Ding, Xiu-Da Peng, Wei Xiong and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of breast cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Ling ChenInstitute of Clinical Medicine, the First Affiliated Hospital of University of South China, Hengyang, China.
Jing ZhongInstitute of Clinical Medicine, the First Affiliated Hospital of University of South China, Hengyang, China.
Jiang-Hua LiuInstitute of Clinical Medicine, the First Affiliated Hospital of University of South China, Hengyang, China.
Duan-Fang LiaoDivision of Stem Cell Regulation and Application, Key Laboratory for Quality Evaluation of Bulk Herbs of Hunan Province, Hunan University of Chinese Medicine, Changsha, China.
Ying-Ying ShenInstitute of Clinical Medicine, the First Affiliated Hospital of University of South China, Hengyang, China.
Xiao-Lin ZhongInstitute of Clinical Medicine, the First Affiliated Hospital of University of South China, Hengyang, China.
Xiao XiaoInstitute of Clinical Medicine, the First Affiliated Hospital of University of South China, Hengyang, China.
Wen-Jun DingInstitute of Clinical Medicine, the First Affiliated Hospital of University of South China, Hengyang, China.
Xiu-Da PengInstitute of Clinical Medicine, the First Affiliated Hospital of University of South China, Hengyang, China.
Wei XiongKey Laboratory of Carcinogenesis of Ministry of Health and Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Cancer Research Institute, Central South University, Changsha, China.
Xu-Yu ZuInstitute of Clinical Medicine, the First Affiliated Hospital of University of South China, Hengyang, China.ORCID 0000-0003-1957-6299
First Affiliated Hospital of University of South China · CNCentral South University · CNHunan University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePokemon, also known as ZBTB7A, belongs to the POZ and Krüppel (POK) family of transcription repressors and is implicated in tumor progression as a key proto-oncogene. This present study aimed at determining the mechanism by which Pokemon inhibits transforming growth factor β (TGFβ)-Smad4 pathway-dependent proliferation arrest of breast cancer cells via specificity protein 1 (SP1).

methodsOver-expressing plasmid or small interfering RNA (siRNA) transfection was used to regulate Pokemon levels. The EdU incorporation assay, MTS assay, and clone formation were used to identify the inhibitory effect of Pokemon siRNA on cell proliferation. Quantitative real-time polymerase chain reaction assay confirmed that Pokemon deletion inhibited the expression of proliferation-associated genes. The dual-luciferase reporter assay, electrophoretic mobility shift assay, and co-immunoprecipitation assay were used to analyze binding between Pokemon, Smad4, and SP1.

resultsPokemon deletion induced proliferation arrest of breast cancer cells and inhibited the expression of proliferation-associated genes, especially

conclusionWe demonstrated that Pokemon binds to SP1 to down-regulate Smad4 expression, thereby promoting proliferation of breast cancer cells. This suggests that Pokemon is a potential TGFβ-signaling participant in breast cancer progression.

Indexed as

Breast neoplasmsCell proliferationPokemon protein, humanSmad4 proteinSP1

Identifiers

PMID30941230
PMCPMC6438826
OpenAlexW2917069409

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.